Copyright Reports & Markets. All rights reserved.

Global Aminoglycosides Antibiotics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Aminoglycosides Antibiotics Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Tobramycin
    • 1.3.3 Gentamicin
    • 1.3.4 Amikacin
    • 1.3.5 Etimicin
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Aminoglycosides Antibiotics Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Aminoglycosides Antibiotics Market Size & Forecast
    • 1.5.1 Global Aminoglycosides Antibiotics Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Aminoglycosides Antibiotics Sales Quantity (2019-2030)
    • 1.5.3 Global Aminoglycosides Antibiotics Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Jemicare
    • 2.1.1 Jemicare Details
    • 2.1.2 Jemicare Major Business
    • 2.1.3 Jemicare Aminoglycosides Antibiotics Product and Services
    • 2.1.4 Jemicare Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Jemicare Recent Developments/Updates
  • 2.2 Teva
    • 2.2.1 Teva Details
    • 2.2.2 Teva Major Business
    • 2.2.3 Teva Aminoglycosides Antibiotics Product and Services
    • 2.2.4 Teva Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Teva Recent Developments/Updates
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Aminoglycosides Antibiotics Product and Services
    • 2.3.4 Novartis Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Novartis Recent Developments/Updates
  • 2.4 Fangyuan-pharma
    • 2.4.1 Fangyuan-pharma Details
    • 2.4.2 Fangyuan-pharma Major Business
    • 2.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Product and Services
    • 2.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Fangyuan-pharma Recent Developments/Updates
  • 2.5 Aike Pharmaceutical
    • 2.5.1 Aike Pharmaceutical Details
    • 2.5.2 Aike Pharmaceutical Major Business
    • 2.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Product and Services
    • 2.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Aike Pharmaceutical Recent Developments/Updates
  • 2.6 Cipla
    • 2.6.1 Cipla Details
    • 2.6.2 Cipla Major Business
    • 2.6.3 Cipla Aminoglycosides Antibiotics Product and Services
    • 2.6.4 Cipla Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Cipla Recent Developments/Updates
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Aminoglycosides Antibiotics Product and Services
    • 2.7.4 Pfizer Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Pfizer Recent Developments/Updates
  • 2.8 Fresenius Kabi
    • 2.8.1 Fresenius Kabi Details
    • 2.8.2 Fresenius Kabi Major Business
    • 2.8.3 Fresenius Kabi Aminoglycosides Antibiotics Product and Services
    • 2.8.4 Fresenius Kabi Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Fresenius Kabi Recent Developments/Updates
  • 2.9 Sun Pharma
    • 2.9.1 Sun Pharma Details
    • 2.9.2 Sun Pharma Major Business
    • 2.9.3 Sun Pharma Aminoglycosides Antibiotics Product and Services
    • 2.9.4 Sun Pharma Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Sun Pharma Recent Developments/Updates
  • 2.10 Hikma
    • 2.10.1 Hikma Details
    • 2.10.2 Hikma Major Business
    • 2.10.3 Hikma Aminoglycosides Antibiotics Product and Services
    • 2.10.4 Hikma Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Hikma Recent Developments/Updates
  • 2.11 Lannett Company
    • 2.11.1 Lannett Company Details
    • 2.11.2 Lannett Company Major Business
    • 2.11.3 Lannett Company Aminoglycosides Antibiotics Product and Services
    • 2.11.4 Lannett Company Aminoglycosides Antibiotics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Lannett Company Recent Developments/Updates

3 Competitive Environment: Aminoglycosides Antibiotics by Manufacturer

  • 3.1 Global Aminoglycosides Antibiotics Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Aminoglycosides Antibiotics Revenue by Manufacturer (2019-2024)
  • 3.3 Global Aminoglycosides Antibiotics Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Aminoglycosides Antibiotics by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Aminoglycosides Antibiotics Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Aminoglycosides Antibiotics Manufacturer Market Share in 2023
  • 3.5 Aminoglycosides Antibiotics Market: Overall Company Footprint Analysis
    • 3.5.1 Aminoglycosides Antibiotics Market: Region Footprint
    • 3.5.2 Aminoglycosides Antibiotics Market: Company Product Type Footprint
    • 3.5.3 Aminoglycosides Antibiotics Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Aminoglycosides Antibiotics Market Size by Region
    • 4.1.1 Global Aminoglycosides Antibiotics Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Aminoglycosides Antibiotics Consumption Value by Region (2019-2030)
    • 4.1.3 Global Aminoglycosides Antibiotics Average Price by Region (2019-2030)
  • 4.2 North America Aminoglycosides Antibiotics Consumption Value (2019-2030)
  • 4.3 Europe Aminoglycosides Antibiotics Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Aminoglycosides Antibiotics Consumption Value (2019-2030)
  • 4.5 South America Aminoglycosides Antibiotics Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Aminoglycosides Antibiotics Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Aminoglycosides Antibiotics Sales Quantity by Type (2019-2030)
  • 5.2 Global Aminoglycosides Antibiotics Consumption Value by Type (2019-2030)
  • 5.3 Global Aminoglycosides Antibiotics Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Aminoglycosides Antibiotics Sales Quantity by Application (2019-2030)
  • 6.2 Global Aminoglycosides Antibiotics Consumption Value by Application (2019-2030)
  • 6.3 Global Aminoglycosides Antibiotics Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Aminoglycosides Antibiotics Sales Quantity by Type (2019-2030)
  • 7.2 North America Aminoglycosides Antibiotics Sales Quantity by Application (2019-2030)
  • 7.3 North America Aminoglycosides Antibiotics Market Size by Country
    • 7.3.1 North America Aminoglycosides Antibiotics Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Aminoglycosides Antibiotics Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Aminoglycosides Antibiotics Sales Quantity by Type (2019-2030)
  • 8.2 Europe Aminoglycosides Antibiotics Sales Quantity by Application (2019-2030)
  • 8.3 Europe Aminoglycosides Antibiotics Market Size by Country
    • 8.3.1 Europe Aminoglycosides Antibiotics Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Aminoglycosides Antibiotics Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Aminoglycosides Antibiotics Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Aminoglycosides Antibiotics Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Aminoglycosides Antibiotics Market Size by Region
    • 9.3.1 Asia-Pacific Aminoglycosides Antibiotics Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Aminoglycosides Antibiotics Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Aminoglycosides Antibiotics Sales Quantity by Type (2019-2030)
  • 10.2 South America Aminoglycosides Antibiotics Sales Quantity by Application (2019-2030)
  • 10.3 South America Aminoglycosides Antibiotics Market Size by Country
    • 10.3.1 South America Aminoglycosides Antibiotics Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Aminoglycosides Antibiotics Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Aminoglycosides Antibiotics Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Aminoglycosides Antibiotics Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Aminoglycosides Antibiotics Market Size by Country
    • 11.3.1 Middle East & Africa Aminoglycosides Antibiotics Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Aminoglycosides Antibiotics Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Aminoglycosides Antibiotics Market Drivers
  • 12.2 Aminoglycosides Antibiotics Market Restraints
  • 12.3 Aminoglycosides Antibiotics Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Aminoglycosides Antibiotics and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Aminoglycosides Antibiotics
  • 13.3 Aminoglycosides Antibiotics Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Aminoglycosides Antibiotics Typical Distributors
  • 14.3 Aminoglycosides Antibiotics Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms.
    According to our (Global Info Research) latest study, the global Aminoglycosides Antibiotics market size was valued at US$ 780 million in 2023 and is forecast to a readjusted size of USD 703 million by 2030 with a CAGR of -1.2% during review period.
    The key players of Aminoglycosides Antibiotics include Jemicare, Teva, Novartis and Fangyuan-pharma. The top four manufacturers hold approximately 15% of the global market share,.
    In terms of product type, Tobramycin is the largest segment, with a share of 34%. And in terms of application, Hospital has a share about 38 percent.
    This report is a detailed and comprehensive analysis for global Aminoglycosides Antibiotics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Aminoglycosides Antibiotics market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
    Global Aminoglycosides Antibiotics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
    Global Aminoglycosides Antibiotics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
    Global Aminoglycosides Antibiotics market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Aminoglycosides Antibiotics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Aminoglycosides Antibiotics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Aminoglycosides Antibiotics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Tobramycin
    Gentamicin
    Amikacin
    Etimicin
    Others
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Jemicare
    Teva
    Novartis
    Fangyuan-pharma
    Aike Pharmaceutical
    Cipla
    Pfizer
    Fresenius Kabi
    Sun Pharma
    Hikma
    Lannett Company
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Aminoglycosides Antibiotics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Aminoglycosides Antibiotics, with price, sales quantity, revenue, and global market share of Aminoglycosides Antibiotics from 2019 to 2024.
    Chapter 3, the Aminoglycosides Antibiotics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Aminoglycosides Antibiotics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Aminoglycosides Antibiotics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Aminoglycosides Antibiotics.
    Chapter 14 and 15, to describe Aminoglycosides Antibiotics sales channel, distributors, customers, research findings and conclusion.

    Buy now